Impact Factor
4.56
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
13.88
2,232 total citations
h5-index
59
h5 depth signal
Cited share
83.6%
138 of 165
Total citations
2,232
Citation footprint
Metric signal
12.66
External metric anchor
Self-citation
0.0%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
320
United States
154
Italy
63
India
56
Spain
35
Citing Fields of Research
Cancer, Autophagy & Apoptosis
99
Oncology
70
Neurodegenerative Disorders
68
Immunology
67
Cancer & Development
49
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,813
Articles tracked across the journal lifetime
Indexed publication set
165
138 cited publications
Last 12 months
92
7.7 publications/month
Open access share
30.4%
28 OA publications in the last year
Leading citing country
China
320 citing publications
Leading citing field
Cancer, Autophagy & Apoptosis
99 citing publications
Latest tracked publication
21 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1981-
v1n1, 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer, Autophagy & Apoptosis
Immunology
Neurodegenerative Disorders
Synthesis
Cellular Membrane Transporters & Receptors
Virology
Oncology
Broad Categories
Pharmacology
Neurodegenerative Disorders
Synthesis
Molecular & Cellular Toxicology
Photochemistry
Parasitology Studies
Neurosciences
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/med.70112
Open DOI
Landscape of Endocytic Effectors for Extracellular Targeted Protein Degradation
Extracellular targeted protein degradation (eTPD) has emerged as a new strategy for regulating the abundance and activity of extracellular and membrane proteins, with prominent potential to address traditionally undruggable targets in on...
02
Acute myeloid leukemia (AML) is the most common form of acute leukemia. It is characterized by unfavorable prognosis, elevated rates of recurrence, short overall survival and high mortality rates. Genetic and epigenetic aberrations contr...
03
DOI 10.1002/med.70110
Open DOI
Aptamer–Based Targeted Protein Degradation: Mechanistic Principles, Delivery Strategies, and Translational Opportunities
Targeted elimination of pathogenic proteins remains a fundamental challenge in therapeutic intervention, particularly for proteins considered “undruggable” by conventional inhibition‐based approaches. Aptamer–based targeted protein degra...
04
DOI 10.1002/med.70116
Open DOI
From Structural Modification to Diverse Pharmacological Activities: Recent Advances and Future Perspectives of Bile Acids
Bile acids (BAs) are amphiphilic steroid acids that exert a broad range of physiological effects—including the regulation of metabolism, immune responses, and inflammatory processes—through activation of specific receptors such as the fa...
05
DOI 10.1002/med.70114
Open DOI
Primetime for the Gasdermins Seesaw in Intestinal Homeostasis and Digestive Disorders
The five pore‐forming gasdermins (GSDMs, namely GSDMA‐E) are best known for executing pyroptosis, a lytic and highly inflammatory form of programmed cell death. Accumulating evidence over the past decade has unveiled diverse nonlytic fun...
06
DOI 10.1002/med.70117
Open DOI
Targeting the Gut Microbiota‐Metabolism Axis: Novel Pharmacological Mechanisms and Translational Application Strategies for Oral Antidiabetic Drugs
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic metabolic disease worldwide, and the clinical prevention and control situation is severe. Although the various antidiabetic drugs currently in clinical use can lower blood glu...
07
DOI 10.1002/med.70111
Open DOI
Covalent Recruitment of E3 Ligases: A New Path for Rational Design of Protein Degraders
The covalent recruitment of E3 ubiquitin ligases is a rapidly advancing strategy in targeted protein degradation (TPD). While traditional non‐covalent PROTACs and molecular glues operate through transient binding equilibria that can limi...
08
DOI 10.1002/med.70109
Open DOI
Targeting the MicroRNA‐Autophagy Axis: Emerging Advances in Cancer Nanotherapeutics
Cancer remains a major clinical challenge due to persistent therapy resistance, despite significant treatment advances. While chemotherapy often induces initial regression, tumors adapt through complex mechanisms, with autophagy playing ...
09
DOI 10.1002/med.70107
Open DOI
Front Cover Image, Volume 46, Issue 6
10
DOI 10.1002/med.70106
Open DOI
Issue Information
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 6, no. 1 (1986)19900917 Notice not published Printed on acid-free paper